Drug Discontinuation

HPS Pharmacies wish to advise that Pfizer Australia has discontinued DBL™ Cephalothin Sodium as follows:

DBL™ Cephalothin Sodium
Cefalotin sodium 1g
ARTG 63203

Internationally registered brands of cefalotin may be accessed via the Special Access Scheme (SAS), if necessary. Please note that SAS alternatives are subject to a longer lead-time and different pricing as they must be sourced internationally.

The Therapeutic Guidelines advise that cefazolin and cefalotin have a similar spectrum of activity. Cefazolin has replaced cefalotin in the guidelines as it is no less effective and has a longer half-life.1

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Pfizer Australia on 1800 675 229 or your pharmacist at HPS Pharmacies.


  1. Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic. Version 16. Melbourne: Therapeutic Guidelines; 2019.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates